Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

Market Cap	8.47B
Revenue (ttm)	1.99B
Net Income (ttm)	301.67M
Shares Out	570.43M
EPS (ttm)	0.53
PE Ratio	28.02
Forward PE	13.14
Dividend	0.27 (1.83%)
Ex-Dividend Date	n/a

Volume	2,918,295
Average Volume	4,316,028
Open	14.89
Previous Close	14.90
Day's Range	14.80 - 15.01
52-Week Range	13.95 - 28.27
Beta	0.66
RSI	34.21
Earnings Date	Apr 25, 2025

About Shenzhen YHLO Biotech

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers automatic chemiluminescence immunoassay analyzers, chemiluminescent immunoassay analyzers, and iModule automatic immunoassay pipelines; and automatic immunofluorescence staining systems, automatic immunofluorescence analysis systems, automatic western blotting analyzers, auto automatic western blot analyzers, and automatic western blotting instruments. It also provides ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,759
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688575

Financial Performance

In 2024, Shenzhen YHLO Biotech's revenue was 1.99 billion, a decrease of -2.99% compared to the previous year's 2.05 billion. Earnings were 301.67 million, a decrease of -15.03%.